ES2056804T3 - Utilizacion de proteina reguladora procedente de foliculos para la elaboracion de un agente terapeutico para el tratamiento del neoplasma de origen gonadal. - Google Patents

Utilizacion de proteina reguladora procedente de foliculos para la elaboracion de un agente terapeutico para el tratamiento del neoplasma de origen gonadal.

Info

Publication number
ES2056804T3
ES2056804T3 ES87114085T ES87114085T ES2056804T3 ES 2056804 T3 ES2056804 T3 ES 2056804T3 ES 87114085 T ES87114085 T ES 87114085T ES 87114085 T ES87114085 T ES 87114085T ES 2056804 T3 ES2056804 T3 ES 2056804T3
Authority
ES
Spain
Prior art keywords
regulatory protein
follicles
neoplasm
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87114085T
Other languages
English (en)
Inventor
Donald L Morton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decatur FRP Partners
Original Assignee
Decatur FRP Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Decatur FRP Partners filed Critical Decatur FRP Partners
Application granted granted Critical
Publication of ES2056804T3 publication Critical patent/ES2056804T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PRESENTA UN METODO DE TRATAR PACIENTES QUE PRESENTAN NEOPLASIAS DE ORIGEN GONADAL, QUE CONSISTE EN ADMINISTRAR UNA DOSIS TERAPEUTICAMENTE EFECTIVA DE PROTEINA REGULADORA DEL FOLICULO (PRF). EL METODO PUEDE SER USADO DURANTE EL PERIODO PREOPERATORIO Y EL POSTOPERATORIO.
ES87114085T 1986-10-03 1987-09-26 Utilizacion de proteina reguladora procedente de foliculos para la elaboracion de un agente terapeutico para el tratamiento del neoplasma de origen gonadal. Expired - Lifetime ES2056804T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/915,074 US4849402A (en) 1986-10-03 1986-10-03 Therapeutic treatment of abnormal cell growth with follicle regulatory protein

Publications (1)

Publication Number Publication Date
ES2056804T3 true ES2056804T3 (es) 1994-10-16

Family

ID=25435172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87114085T Expired - Lifetime ES2056804T3 (es) 1986-10-03 1987-09-26 Utilizacion de proteina reguladora procedente de foliculos para la elaboracion de un agente terapeutico para el tratamiento del neoplasma de origen gonadal.

Country Status (8)

Country Link
US (1) US4849402A (es)
EP (1) EP0267402B1 (es)
JP (1) JPH01168622A (es)
AT (1) ATE91236T1 (es)
AU (1) AU600034B2 (es)
CA (1) CA1295940C (es)
DE (1) DE3786442T2 (es)
ES (1) ES2056804T3 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4764502A (en) * 1983-03-15 1988-08-16 University Of Southern California Intragonadal regulatory protein
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms

Also Published As

Publication number Publication date
AU7931487A (en) 1988-04-14
DE3786442D1 (de) 1993-08-12
EP0267402B1 (en) 1993-07-07
EP0267402A2 (en) 1988-05-18
JPH01168622A (ja) 1989-07-04
DE3786442T2 (de) 1993-10-21
US4849402A (en) 1989-07-18
EP0267402A3 (en) 1990-05-23
AU600034B2 (en) 1990-08-02
CA1295940C (en) 1992-02-18
ATE91236T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
DE3382458D1 (de) Haarwuchsmittel.
DE68919358T2 (de) Zusammensetzung zur behandlung der schizophrenie.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE3774918D1 (de) Cancerostatisches mittel.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ES2039354T3 (es) Tratamiento transdermico del dolor y de la inflamacion con acidos 2-amino-3-aroilbencenaceticos, sales y esteres.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
ES2074565T3 (es) Empleo de melatonina para tratar el sindrome pre-menstrual.
DE69201128D1 (de) Behandlung von neoplastischen krankenheiten mit interleukin-10.
IL81573A (en) Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
JPS57193411A (en) Prevention of prostatic hyperplasia and therapeutical drug
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
ES2123004T3 (es) Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
ES2056804T3 (es) Utilizacion de proteina reguladora procedente de foliculos para la elaboracion de un agente terapeutico para el tratamiento del neoplasma de origen gonadal.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
SE8303729D0 (sv) Terapeutiskt medel for behandling av allergiska sjukdomstillstand, immunkomplexsjukdomar och tumorer
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
IT1229471B (it) Apparecchiatura perfezionata per il trattamento curativo del cuoio capelluto
IT1182847B (it) Farmaci per malattie provocate da immunoanomalia

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267402

Country of ref document: ES